ReviewNature reviews. Drug discovery2022
Thinking outside the box: non-canonical targets in multiple sclerosis.
Laura Bierhansl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this papercites it